Patents by Inventor Qianli Wang

Qianli Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9259476
    Abstract: The present invention provides for monophosphorylated lipid A derivatives and carbohydrate derivatives that are useful as agents in the treatment of diseases and conditions, including cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I-IV. In addition, methods for the treatment of cancers are provided.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: February 16, 2016
    Assignee: WAYNE STATE UNIVERSITY
    Inventors: Zhongwu Guo, Qianli Wang, Shouchu Tang
  • Patent number: 9056141
    Abstract: The present invention relates to linker molecules that readily conjugate cellular recognition ligand at one end and drug payload at the other, and are useful in treating or preventing cancer, an autoimmune disease, an inflammatory condition, a central nervous system disorder or an infection.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: June 16, 2015
    Assignee: SynChem, Inc.
    Inventors: Ze-Qi Xu, Qianli Wang, Augustine Rudolph Joseph, Zhiqiang Fang
  • Publication number: 20140356367
    Abstract: The present invention provides for monophosphorylated lipid A derivatives and carbohydrate derivatives that are useful as agents in the treatment of diseases and conditions, including cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I-IV. In addition, methods for the treatment of cancers are provided.
    Type: Application
    Filed: August 18, 2014
    Publication date: December 4, 2014
    Inventors: Zhongwu Guo, Qianli Wang, Shouchu Tang
  • Patent number: 8809285
    Abstract: The present invention provides for monophosphorylated lipid A derivatives and carbohydrate derivatives that are useful as agents in the treatment of diseases and conditions, including cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I-IV. In addition, methods for the treatment of cancers are provided.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: August 19, 2014
    Assignee: Wayne State University
    Inventors: Zhongwu Guo, Qianli Wang, Shouchu Tang
  • Publication number: 20130323169
    Abstract: The present invention relates to linker molecules that readily conjugate cellular recognition ligand at one end and drug payload at the other, and are useful in treating or preventing cancer, an autoimmune disease, an inflammatory condition, a central nervous system disorder or an infection.
    Type: Application
    Filed: May 31, 2013
    Publication date: December 5, 2013
    Inventors: Ze-Qi Xu, Qianli Wang, Augustine Rudolph Joseph, Zhiqiang Fang
  • Publication number: 20120190633
    Abstract: The present invention provides for monophosphorylated lipid A derivatives and carbohydrate derivatives that are useful as agents in the treatment of diseases and conditions, including cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I-IV. In addition, methods for the treatment of cancers are provided.
    Type: Application
    Filed: July 30, 2010
    Publication date: July 26, 2012
    Inventors: Zhongwu Guo, Qianli Wang, Shouchu Tang